Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
Journal: Journal of the National Cancer Institute
Published: March 30, 2020
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
Journal: The New England journal of medicine
Published: June 04, 2019
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Journal: The New England journal of medicine
Published: June 05, 2018
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Journal: The New England journal of medicine
Published: September 29, 2015
Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study.
Journal: Clinical breast cancer
Published: August 15, 2013
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study.
Journal: Investigational new drugs
Published: November 13, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026